British Columbia Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,727
| Closed | -$908K | – | 687 |
|
|
2025
Q1 | $908K | Buy |
3,727
+17
| +0.5% | +$4.14K | 0.01% | 684 |
|
|
2024
Q4 | $1.22M | Buy |
3,710
+386
| +12% | +$127K | 0.01% | 690 |
|
|
2024
Q3 | $1.11M | Sell |
3,324
-488
| -13% | -$163K | 0.01% | 689 |
|
|
2024
Q2 | $1.04M | Buy |
3,812
+1,256
| +49% | +$343K | 0.01% | 700 |
|
|
2024
Q1 | $884K | Buy |
2,556
+69
| +3% | +$23.9K | 0.01% | 739 |
|
|
2023
Q4 | $803K | Buy |
2,487
+477
| +24% | +$154K | 0.01% | 734 |
|
|
2023
Q3 | $720K | Buy |
2,010
+38
| +2% | +$13.6K | 0.01% | 715 |
|
|
2023
Q2 | $748K | Hold |
1,972
| – | – | 0.01% | 714 |
|
|
2023
Q1 | $945K | Sell |
1,972
-3
| -0.2% | -$1.44K | 0.01% | 658 |
|
|
2022
Q4 | $830K | Sell |
1,975
-218
| -10% | -$91.7K | 0.01% | 680 |
|
|
2022
Q3 | $915K | Sell |
2,193
-393
| -15% | -$164K | 0.01% | 667 |
|
|
2022
Q2 | $1.28M | Sell |
2,586
-865
| -25% | -$428K | 0.01% | 643 |
|
|
2022
Q1 | $1.94M | Sell |
3,451
-451
| -12% | -$254K | 0.01% | 664 |
|
|
2021
Q4 | $2.95M | Sell |
3,902
-216
| -5% | -$163K | 0.02% | 595 |
|
|
2021
Q3 | $3.07M | Sell |
4,118
-3
| -0.1% | -$2.24K | 0.02% | 585 |
|
|
2021
Q2 | $2.66M | Buy |
4,121
+475
| +13% | +$306K | 0.02% | 640 |
|
|
2021
Q1 | $2.08M | Sell |
3,646
-92
| -2% | -$52.5K | 0.02% | 648 |
|
|
2020
Q4 | $2.18M | Sell |
3,738
-96
| -3% | -$56K | 0.02% | 638 |
|
|
2020
Q3 | $1.98M | Buy |
3,834
+252
| +7% | +$130K | 0.02% | 598 |
|
|
2020
Q2 | $1.62M | Buy |
3,582
+1,134
| +46% | +$512K | 0.02% | 606 |
|
|
2020
Q1 | $858K | Sell |
2,448
-2,790
| -53% | -$978K | 0.01% | 599 |
|
|
2019
Q4 | $1.94M | Buy |
+5,238
| New | +$1.94M | 0.01% | 683 |
|